Michael Kocher, based in Denmark, is currently a CEO at Xellia Pharmaceuticals. Michael Kocher brings experience from previous roles at Sandoz, Rowex Ltd., Austria HBHG Pharma GmbH and Novartis. Michael Kocher holds a Master in Chemistry @ Johannes Gutenberg University Mainz. With a robust skill set that includes Business Development, Business Strategy, Consumer Products, Cosmetics, Cross-functional Team Leadership and more. Michael Kocher has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Michael Kocher?
Find contact details for 700 million professionals.